Monoaminergic Psychomotor Stimulants: Discriminative Stimulus Effects and Dopamine Efflux
Authors:
- Carol A. ParonisCPCarol A. Paronis
- Jared MartinJMJared Martin
- Ramya DesaiRDRamya Desai
- Jack BergmanJBJack Bergman
- 1 June 2010
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 333 (3) , 834-843
Abstract
The present studies were conducted to investigate the relationship between discriminative stimulus effects of indirectly acting monoaminergic psychostimulants and their ability to increase extracellular levels of dopamine (DA) in the nucleus accumbens (NAcb) shell. First, the behavioral effects of methamphetamine (MA), cocaine (COC), 1-[2-[bis(4-fluorophenyl-)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909), d-amphetamine, and methylphenidate were established in rats trained to discriminate intraperitoneal injections of 0.3 mg/kg MA from saline. In other studies, in vivo microdialysis was used to determine the effects of MA, COC, and GBR 12909 on extracellular DA levels in the NAcb shell. Results show that all drugs produced dose-related and full substitution for the discriminative stimulus effects of 0.3 mg/kg MA. In microdialysis studies, cumulatively administered MA (0.3–3 mg/kg), COC (3–56 mg/kg), and GBR 12909 (3–30 mg/kg) produced dose-dependent increases in DA efflux in the NAcb shell to maxima of approximately 1200 to 1300% of control values. The increase in DA levels produced by MA and COC was rapid and short-lived, whereas the effect of GBR 12909 was slower and longer lasting. Dose-related increases in MA lever selection produced by MA, COC, and GBR 12909 corresponded with graded increases in DA levels in the NAcb shell. Doses of MA, COC, and GBR 12909 that produced full substitution increased DA levels to approximately 200 to 400% of control values. Finally, cumulatively administered MA produced comparable changes in DA levels in both naive and 0.3 mg/kg MA-trained rats. These latter results suggest that sensitization of DA release does not play a prominent role in the discriminative stimulus effects of psychomotor stimulants.Keywords
This publication has 40 references indexed in Scilit:
- Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeysPharmacology Biochemistry and Behavior, 2007
- Dopaminergic responses to self‐administered cocaine in Rhesus monkeys do not sensitize following high cumulative intakeEuropean Journal of Neuroscience, 2006
- Relationship between in Vivo Occupancy at the Dopamine Transporter and Behavioral Effects of Cocaine, GBR 12909 [1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and Benztropine AnalogsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Effects of 4′-Chloro-3α-(diphenylmethoxy)-tropane on Mesostriatal, Mesocortical, and Mesolimbic Dopamine Transmission: Comparison with Effects of CocaineThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Changes in extracellular dopamine during cocaine self‐administration in squirrel monkeysSynapse, 2005
- Effects of N-Substituted Analogs of Benztropine: Diminished Cocaine-Like Effects in Dopamine Transporter LigandsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Drug Addiction, Dysregulation of Reward, and AllostasisNeuropsychopharmacology, 2001
- Behavioral Changes and [123I]IBZM Equilibrium SPECT Measurement of Amphetamine-Induced Dopamine Release in Rhesus Monkeys Exposed to Subchronic AmphetamineNeuropsychopharmacology, 2000
- Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysisPharmacology Biochemistry and Behavior, 1989